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Abstract
: Female genital schistosomiasis (FGS) is a neglected andBackground
disabling gynaecological disorder that is difficult to diagnose and is part of
the wider spectrum of urogenital disease caused by the waterborne
parasite  . Over 90% of human schistosomiasisSchistosoma haematobium
cases are found in sub-Saharan Africa with 3.8 million people infected with
schistosomes in Zambia. Reported FGS prevalence ranges from 33-75% of
those with urinary schistosomiasis in endemic areas, suggesting a
potentially high FGS burden in Zambia alone. The Bilharzia and HIV
(BILHIV) study evaluated home self-sampling genital collection methods for
the diagnosis of FGS.
: Eligible participants included non-pregnant, sexually activeMethods
women aged 18-31 who were previously recruited for the HPTN 071
(PopART) trial in Livingstone, Zambia. Household demographic and
symptom questionnaires were administered by community workers.
Participants were offered vaginal and cervical self-swabs and a urine cup.
Cervicovaginal lavage (CVL) was performed in clinic by midwives.
Information was collected from participants on the acceptability and
feasibility of genital self-sampling.
: From January-August 2018, 603 women were enrolled, andResults
87.3% (527/603) completed clinic follow up. A high proportion of
participants indicated that self-collection of specimens was “easy” or “very
easy” on a 5-point Likert scale. A high proportion of women would be willing
to self-collect all three specimens again in future: vaginal swab 96.7%
(583/603), cervical swab 96.5% (582/603), and urine 96.2% (580/603).
Home-based self-sampling was preferred over provider-based sampling in
the clinic due to greater privacy 58.5% (353/603), convenience 46.3%
(279/603) and need for transportation 15.9% (96/603).
: Home based genital self-sampling for FGS diagnosis isConclusions
highly acceptable. This scalable method may inform future efforts for
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 highly acceptable. This scalable method may inform future efforts for
community-based diagnosis of FGS.
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Introduction
Human schistosomiasis is a waterborne parasitic disease caused 
by blood flukes of the genus Schistosoma1,2. It constitutes a sig-
nificant public health problem causing the loss of 1,440 million 
years of full health worldwide, with approximately 659 mil-
lion people at risk of acquiring infection2,3. More specifically, 
Schistosoma haematobium affects both the urinary as well as 
the genital tract. In female genital schistosomiasis (FGS)1, para-
site egg deposition occurs in the genital tract and it is character-
ized by histologic vaginal or cervical mucosal inflammation4 and 
unique clinical findings5. FGS has been associated with infertil-
ity, a condition associated with negative social and psychologi-
cal impacts in many low-income countries6. In addition, obser-
vational studies have suggested an association between FGS and 
prevalent HIV infection7,8, and HIV transmission and acquisition9.
Genital self-sampling has been described in the diagnosis of 
reproductive tract infections (RTI)10–12 in both adults and 
adolescents13 and has enhanced access to health services among 
hard-to-reach populations such as adolescents/young people14, 
and those who do not regularly access health screening 
services15,16. A high proportion of women, including those from 
resource-limited settings have been found to prefer vaginal 
specimen self-collection10,17 compared with clinic-based 
sampling. In addition to acceptability, two other factors make 
genital self-sampling advantageous; 1) the availability of vaginal 
self-sampling is effective for improving participation in specific 
RTI screening programmes and 2) the sensitivity of PCR- 
based assays on self-collected specimens compares favourably 
with physician-performed sampling16,18.
The Bilharzia and HIV (BILHIV) study’s primary aim was to 
validate home-based self-sampling for the detection of 
Schistosoma DNA with vaginal and cervical swabs against provider 
obtained cervicovaginal lavage in a clinic setting in an endemic 
area in Zambia. The BILHIV study previously found that 
Schistosoma DNA was more frequently detected in genital self- 
collected specimens compared to clinic-collected cervicovaginal 
lavage19. Here, we describe the acceptability and feasibility of 
genital self-sampling for the detection of Schistosoma DNA in 
the BILHIV study. In addition, this study also analyses the 
demographic predictors for participant’s preference of home- 
based self-sampling over clinic-based sampling.
Methods
Study setting and participants
The Bilharzia and HIV (BILHIV) study was a cross-sectional 
study nested within two of the 12 HPTN 071 (PopART) 
communities in Livingstone, southern province of Zambia20. 
HPTN 071 (PopART) was a trial to measure the impact of an HIV 
combination prevention package, including universal test and 
treat20. Non-pregnant, sexually active women aged 18–31 who had 
previously been recruited for the HPTN 071 (PopART) population 
cohort were eligible for inclusion in BILHIV.
Sample collection and questionnaire
Between January and August 2018, specially trained population 
cohort research assistants visited women during the population 
cohort 36-month end of study follow up and enquired regarding 
an “expression of interest” in the BILHIV study. At a subsequent 
home visit, BILHIV Community Workers (BCW) evaluated 
study eligibility, provided participants with study information 
in the language of their choice, along with FGS education, and 
obtained written informed consent.
At the home visit, the BCW provided participating women with 
instructions for urine collection and cervical and vaginal self- 
swabs using educational materials including an information sheet 
with diagrams of the female anatomy, model vagina, and test 
swabs. Photos in the World Health Organization’s “Female 
Genital Schistosomiasis Pocket Atlas” were also displayed as a 
visual aid. As shown in Figure 1, these educational materials were 
used to explain and demonstrate the procedure of self-collection 
of genital specimens. For swab self-collection, participants were 
instructed to hold a 6-inch vaginal swab (PrimeSwab, Longhorn 
Diagnostics, Texas, USA) at the 2 3/8-inch score mark and insert 
the swab vaginally until their fingers touched the labia minora. 
Participants moved the swab in a circular motion against the 
vaginal walls for a minimum of 15 repetitions. Similarly, for the 
cervical swab, participants were instructed to hold a 6 3/4-inch 
flocked swab (Miraclean, Shenzen, China) with a quadrilateral 
kite-shaped tip at the non-flocked end of the swab body and 
insert the swab vaginally until they met noticeable resistance. The 
participant then performed swab rotation as described above. The 
participant broke the shaft of each swab and placed the vaginal and 
cervical swabs in separate screw-capped microtubes (STARLAB, 
Hamburg, Germany). Both swab specimens and urine were placed 
in cool boxes for transportation to the laboratory.
Following written informed consent and specimen collection, 
the participants completed a questionnaire, with responses cap-
tured on hand-held tablets. The questionnaire assessed basic 
demographics, information regarding genital symptoms, sexual 
behaviour and also the participant’s assessment of the accept-
ability of self-sampling, through their responses to 15 questions 
(Extended data21; Table 1).
At a later date, participating women who were not currently 
menstruating attended Livingstone Central Hospital (LCH) cer-
vical cancer screening clinic where a trained midwife performed 
a cervicovaginal lavage and images of the vagina and cervix 
were captured with a point-of-care colposcope (MobileODT, Tel 
Aviv Israel) (Sturt, A et al. paper under review).
Ethics and informed consent
All eligible participants providing written consent were recruited 
into the study. Participants who were unable to provide writ-
ten informed consent were recruited in the presence of a wit-
ness with the participant placing their thumbprint on the consent 
form. The study was approved by the University of Zambia 
Biomedical Research Ethics Committee (reference number: 
011-08-17), the Zambia National Health Research Authority and 
the London School of Hygiene and Tropical Medicine research 
ethics committee (reference number: 14506). Permission to 
conduct the study was given by the Livingstone District health 
office and the superintendent of the Livingstone Central Hospital.
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Figure 1. (A) The Bilharzia and HIV Community Workers (BCWs) demonstrating the use of genital self-swabs by using a 3D model; (B) BCWs 
teaching by using the WHO female genital schistosomiasis atlas; (C) BCWs delivering questionnaires in hand-held tablets. Photo credit: A. 
Bustinduy; oral permission was obtained from subjects to publish these images. Images have also been edited (pixelated and cropped) to 
keep the identity of the subjects anonymous.
Data management and statistical methods
Acceptability in our study was measured by the following outcomes: 
the proportion of women who rated home based self-sampling to 
be “easy” or “very easy” (for each of urine, vaginal, cervical 
self-sampling), the proportion who didn’t experience “pain” while 
self-sampling (for each of vaginal, cervical self-sampling), the 
proportion who were willing to self-sample again “in the 
future” (for each of urine, vaginal, cervical self-sampling), and 
the proportion who would prefer to “sample at home” (versus 
sampling in the clinic).
Participant data were entered using Open Data Kit Collect22. 
Continuous variables were summarized by mean and interquar-
tile range (IQR), and categorical variables by frequency and per-
centage. Participant characteristics were compared between the 
two communities using Wilcoxon-Mann-Whitney, chi-squared, 
and Fisher’s exact tests. The Mantel-Haenszel approach was used 
to obtain crude and age-adjusted odds ratios for the association 
of demographic variables with a participant’s preference for 
home-based versus clinic-based sampling.
Results
Of 1104 women screened for BILHIV eligibility, 54.5% 
(603/1105) were enrolled and all completed an initial home-based 
visit. Of those completing the initial home visit, 87.4% (527/603) 
completed clinic follow up (Figure 2). The median age was 24 years 
(IQR 22-28). More than half of participants, 60.4% (364/603), 
completed secondary school education and 59% (356/603) 
spoke primarily Nyanja (Table 1).
Acceptability and feasibility
Out of 603 women recruited, a high proportion indicated that 
self-collection of genital specimens was “easy” or “very easy” 
on a 5-point Likert scale for urine collection (96.2%; 580/603), 
vaginal swab (94.9%; 572/603), and cervical swab (86.6%; 
522/603) (Figure 3; Table 2). Most participants indicated that 
they would be willing to self-collect again in the future: urine 
96.2% (580/603), vaginal swab 96.7% (583/603) and cervical 
swab 96.5% (582/603). Substantially less than half of partici-
pants reported that it was “painful” to self-collect vaginal speci-
mens (3.3%; 20/603) and cervical specimens (6.8%; 41/603) 
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Table 1. Baseline characteristics of 603 Zambian women living in Schistosoma haematobium endemic 
areas near the Zambezi river by community.
Characteristics Overall (n=603)
Community A 
(n=319)
Community B 
(n=284) p-value*
Age in years – Median (IQR) 24 (22-28) 26 (23-29) 24 (21-27) <0.001
Marital Status Single 258 (42.8%) 110 (34.5%) 148 (52.1%) <0.001
Married or 
Cohabitating
320 (53.1%) 193 (60.5%) 127 (44.7%)
Divorced or 
Separated
23 (3.8%) 15 (4.7%) 8 (2.8%)
Widowed 2 (0.3%) 1 (0.3%) 1 (0.4%)
Language spoken Nyanja 356 (59.0%) 160 (50.2%) 196 (69.0%) <0.001
Tonga 127 (21.1%) 93 (29.2%) 34 (12.0%)
Lozi 86 (14.3%) 48 (15.1%) 38 (13.4%)
Bemba 30 (5.0%) 17 (5.3%) 13 (4.6%)
English only 4 (0.7%) 1 (0.3%) 3 (1.1%)
Education (highest level) Any Primary School 167 (27.7%) 117 (36.7%) 50 (17.6%) <0.001
Any Secondary 
School
364 (60.4%) 173 (54.2%) 191 (67.3%)
Training in a Trade 59 (9.8%) 20 (6.3%) 39 (13.7%)
Degree or Higher 3 (0.5%) 3 (0.9%) 0 (0.0%)
None 10 (1.7%) 6 (1.9%) 4 (1.4%)
Employment status Working 408 (67.7%) 200 (62.7%) 208 (73.2%) 0.006
Not Working 195 (32.3%) 119 (37.3%) 76 (26.8%)
Current water contact None 512 (84.9%) 263 (82.5%) 249 (87.7%) 0.02
At Least Weekly 18 (3.0%) 11 (3.5%) 7 (2.5%)
Every 1–2 Months 30 (5.0%) 24 (7.5%) 6 (2.1%)
Every 6–12 Months 43 (7.1%) 21 (6.6%) 22 (7.8%)
Childhood water contact None 186 (30.9%) 96 (30.1%) 90 (31.7%) 0.22
At Least Weekly 381 (63.2%) 208 (65.2%) 173 (60.9%)
Every 1–2 Months 24 (4.0%) 12 (3.8%) 12 (4.2%)
Every 6–12 Months 12 (2.0%) 3 (0.9%) 9 (3.2%)
No 572 (94.8%) 294 (92.2%) 278 (97.9%) 0.006
Self-reported history of 
schistosomiasis
Yes 25 (4.2%) 20 (6.3%) 5 (1.8%)
Maybe 6 (1.0%) 5 (1.6%) 1 (0.4%)
*comparison of Community-A vs Community-B
(Table 2). A high proportion of women (95.7%; 577/603) indicated 
that they would ‘recommend self-sampling to my friends’. Over-
all, most women preferred to collect specimens at home (90.0%; 
543/603), compared with clinic-based sampling (10.0%; 60/603), 
(Table 3). Women from both communities preferred to self-col-
lect specimens from home (Community A: 89.3%, 285/319; Com-
munity B: 90.9%, 258/284; p=0.5) compared with attending the 
health facility. Participants preferred “self-sampling at home” 
over provider-based sampling in the clinic due to greater privacy 
(58.5%; 353/603), convenience (46.3%; 279/603) and lack 
of transportation (15.9%; 96/603) (Table 3). Participants in 
Community B were more confident (99.3%; 282/284) than par-
ticipants in Community A (91.5%; 292/319) (p<0.001) that they 
collected the specimens correctly.
Overall, there was little evidence that education, marital status, 
community of residence, employment status, language spoken, 
and age were associated with a participant’s preference for home- 
based sampling over clinic-based sampling (Table 4). Given 
that the preference for self-sampling was universal across the 
groups examined in the crude analysis, we did not undertake 
multivariable analysis.
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Figure 2. The Bilharzia and HIV study enrolment and sampling flow chart.
Figure 3. Ease of self-sampling in 603 Zambian women by specimen type.
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Table 2. Acceptability of genital self-sampling for women from the BILHIV study (n=603).
Question Very easy % (n)
Easy 
% (n)
Neutral 
% (n)
A little difficult 
% (n)
Very difficult 
% (n)
I found vaginal self-sampling to be 34.5 (208) 60.4 (364) 2.0 (12) 3.2 (19) 0 (0)
I found cervical self-sampling to be 26.2 (158) 60.4 (364) 5.0 (30) 8.5 (51) 0 (0)
I found collecting my own urine sample to be 56.2 (339) 40.0 (241) 1.7 (10) 2.0 (12) 0.2 (1)
Question Strong yes Yes Maybe No Strong no
I would be willing to take a vaginal self-sample 
in the future.
42.1 (254) 54.6 (329) 2.2 (13) 1.2 (7) 0 (0)
I would be willing to take a cervical self-sample 
in the future.
37.0 (223) 60.0 (359) 2.5 (15) 1.0 (6) 0 (0)
I would be willing to takes a urine self-sample in 
the future.
38.6 (233) 58.4 (352) 2.3 (14) 0.7 (4) 0 (0)
I would recommend self-sampling to my 
friends.
29.0 (175) 66.7 (402) 1.8 (11) 2.0 (12) 0.5 (3)
Self-collecting a vaginal swab was painful. 0.33 (2) 3.0 (18) 3.7 (22) 77.1 (465) 15.9 (96)
Self-collecting a cervical swab was painful. 0 (0) 6.8 (41) 9.6 (58) 71.3 (430) 12.3 (74)
I am confident I collected the specimens 
properly.
29.0 (175) 66.2 (399) 2.7 (16) 2.2 (13) 0 (0)
I feel confident I collected a sample from my 
vagina.
25.7 (155) 72.3 (436) 1.3 (8) 0.7 (4) 0 (0)
I feel confident I collected a sample from my 
cervix.
24.5 (148) 71.6 (432) 3.5 (21) 0.3 (2) 0 (0)
Table 3. Results of the BILHIV study patient experience surveys for 603 women 
living in Schistosoma haematobium endemic areas in Livingstone, Zambia*.
Question Participant responses % (n)*
Do you prefer to take your samples 
at home, or would you prefer to 
take samples at the clinic?
Clinic 10.0 (60)
Home 90.0 (543)
I prefer doing samples at home 
because** It is more convenient 51.4 (279)
I don’t have transportation 17.7 (96)
I don’t have childcare 2.6 (14)
I need to work 6.2 (34)
I have more privacy at home 65.0 (353)
It is easier to sample at home 66.3 (360)
Other reason 11.4 (62)
I prefer having samples performed 
in clinic because** I don’t have privacy at home 26.7 (16)
I had discomfort with 
collecting my own samples 13.3 (8)
I was unsure if I did the 
sampling properly 30.0 (18)
I’d like more supervision 28.3 (17)
Other 28.3 (17)
*Proportions for home-based testing have a denominator of 543, proportions for clinic-based 
testing have a denominator of 60
**Participants could choose more than one answer
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Table 4. Factors associated with the choice of home-based sampling over clinic-based sampling, adjusted for age.
Exposure n (home-based 
sampling)/N (%) Crude OR 95% CI aOR 95% CI p-value
Education None or any primary 
school
166/177 (94%) reference reference 0.31
Any secondary 
school
323/364 (89%) 0.52 0.26 – 1.05 0.45 0.22 – 0.91
Trade training or a 
degree
54/62 (87%) 0.45 0.17 – 1.18 0.47 0.17 – 1.27
Language* Nyanja 328/356 (92%) reference reference 0.11
Tonga 114/127 (90%) 0.75 0.37 – 1.50 0.75 0.38 – 1.52
Lozi 72/86 (84%) 0.44 0.22 – 0.88 0.44 0.22 – 0.88
Bemba 26/30 (87%) 0.55 0.18 – 1.71 0.55 0.18 – 1.70
Marital status Single 228/258 (88%) reference reference 0.49
Married 292/320 (91%) 1.37 0.79 – 2.37 1.58 0.85 – 2.95
Divorced or widowed 23/25 (92%) 1.51 0.34 – 6.77 1.61 0.31 – 8.34
District Community A 285/319 (89%) reference reference 0.54
Community B 258/284 (91%) 1.18 0.69 – 2.03 1.14 0.66 – 1.97
Employment 
status
Not working 367/408 (90%) reference reference 0.91
Working 176/195 (90%) 1.03 0.58 – 1.84 1.07 0.60 – 0.90
Age (years) 18–22 144/158 (91%) reference -- -- 0.62
23–26 207/228 (91%) 0.96 0.47 – 1.95 -- --
27–31 192/217 (89%) 0.75 0.37 – 1.49 -- --
Discussion
FGS is a chronic gynaecologic condition that afflicts vulner-
able women and girls in sub-Saharan Africa. Current diagnostic 
strategies are limited as they rely on resources that are seldom 
available in low-income settings23. A self-collection method that 
minimises reliance on health care providers would represent a 
scalable alternative method for FGS community-based diagnosis 
in endemic resource limited settings, but only if it is an accept-
able procedure to perform. Home based genital self-sampling for 
the diagnosis of FGS was highly acceptable among women aged 
18 to 31 years of age enrolled in the BILHIV study in Zambia. 
All participating women provided all three self-collected specimens 
(urine, vaginal and cervical swabs), and a high proportion found 
vaginal self-sampling and cervical self-sampling “easy” or “very 
easy”.
Our study is in agreement with other studies in which self-swabs 
were acceptable to women in geographically and ethnically 
diverse target populations10,18,24. In a study of Haitian immigrants 
living in the USA, the acceptability of unsupervised cervical 
HPV self-sampling using written instructions revealed that self- 
sampling was more acceptable to the majority of the women than 
clinician-administered sampling24,25, and it increased screening 
coverage among female clinic non-attendees15,26. Also in an Italian 
study, cervical self-sampling using either a brush or a self-lavaging 
device was acceptable and both modalities were preferred to 
clinician-sampling (n=117, 68%)27. A systematic review on the 
acceptability of self-sampled screening for HPV DNA reported 
that self-sampling was highly acceptable among study participants 
in 37 studies from 24 countries across five continents25. Despite 
heterogeneity in study design, the studies in this meta-analysis 
suggest that self-sampling is well accepted by participants 
regardless of education, marital status, community of residence, 
employment status, language spoken, and age. Supported by these 
data we can conclude that our findings are likely generalizable 
across geographic areas and among women of varying educational 
background, cultures, and ethnic groups.
Substantially over half of the women in the BILHIV study 
reported that self-collection of specimens was “easy” or “very 
easy” (urine 96.2%, vaginal swab 94.9% and cervical swab 
86.6%). This is consistent with other studies that showed that study 
participants found genital self-sampling or the use of a self-sam-
pling device easy to use24,25. The proportion with this outcome was 
slightly lower for cervical than vaginal sampling. Swab length 
and more invasive technique may account for the lower propor-
tion of women who found cervical self-sampling “easy” or “very 
easy”, compared with vaginal self-sampling. As another measure 
of acceptability, over 96% of women in the BILHIV study indi-
cated that they were willing to self-collect all three specimens again 
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in the future, which is similar to proportions reported in HPV 
self-collection research using cervical swabs24,28 and curable 
STI research using vaginal swabs29. Our study, as others, further 
showed that a high proportion of the women indicated that they 
would recommend self-sampling to a friend25. This shows prom-
ise for the future use of peer-encouragement in the use of genital 
self-sampling procedures.
Our study also revealed that 90.0% of participants preferred 
self-sampling at home over provider-based sampling at the 
clinic. Our findings are similar to studies reporting a high pref-
erence for home self-sampling25,27,28. However, a recent meta-
analysis found that the pooled estimate of women who preferred 
self-sampling to clinic based sampling was 59% (48 – 69%)25. 
There are some possible explanations for this. While a binary 
outcome was evaluated in the meta-analysis, the individual rea-
sons for preferring home-based self-sampling to health-facility 
sampling vary across studies. In the BILHIV study questionnaire, 
the questions regarding preferences for home vs. clinic sampling 
included a comprehensive range of options that included ‘privacy’, 
‘convenience’, ‘transportation’, ‘work conflicts’, ‘no child-care’, 
and ‘ease’ among others. Second, other work reports that some 
women preferred clinic sampling to home based self-sampling 
because they were not comfortable with touching their genital 
areas, they were unsure about the safety of self-testing, or they 
were concerned they would perform the test incorrectly30.
This study benefited from HPTN 071 (PopART) because HPTN 
071 (PopART) staff introduced the BILHIV study to all prospec-
tive BILHIV participants that enabled them to be familiar with 
the study even before it began. Further, the BILHIV study was 
implemented in communities that were already familiar with 
the organization and the staff that worked under the HPTN 071 
(PopART) study. In addition, former HPTN 071 (PopART) staff 
in the two study communities continued to work in the same 
communities under the BILHIV study. This enabled improved 
study performance because of the existing rapport between BIL-
HIV staff and the community members. Standardized question-
naires were used to reduce observer bias and were performed at 
the time of self-sampling to minimize recall bias. However, it is 
important to note that the participation in the BILHIV study was 
limited to women who took part in the HPTN 071 (PopART) 
population cohort. In this scenario, bias may be related to a Haw-
thorne effect. This observer effect can occur as participants in a 
study alter their behaviour as a result of regular follow-up within 
a cohort31. The HPTN 071 (PopART) population cohort was 
selected through a random sampling of households and random 
selection of one individual within each household31. BILHIV 
study participants were selected by querying eligible members of 
the population cohort for an “expression of interest”. There may 
be selection bias, in that women who expressed an interest in 
participating in the study may not be representative of the popula-
tion as a whole.
Conclusion
We have shown high acceptability and feasibility of genital self-
sampling for the diagnosis of FGS in young women (18–31 
years) in a schistosomiases endemic area in Zambia. This practice 
has potential to increase FGS surveillance in other endemic pop-
ulations. The majority of participants reported that specimen 
self-collection was “easy” or “very easy” with high willingness to 
participate in future home-based self-sampling. Results can inform 
future efforts for community-based diagnosis of FGS.
Data availability
Underlying data
LSHTM Data Compass: BILHIV acceptability dataset, 
https://doi.org/10.17037/DATA.0000161832.
This data is under restricted access due to the assurance given 
to participants that responses would be kept completely 
confidential. This is particularly important due to the sensitivity 
of the data produced. The data set can be accessed by completing 
the Request Form, which requires that the intended use for the 
data is specified. Data available under the LSHTM Data Compass 
Data Sharing Agreement.
Extended data
Figshare: Extended data_Figshare.docx, https://doi.org/10.6084/
m9.figshare.12023382.v121.
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